These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Genetic changes in contralateral bronchioloalveolar carcinomas of the lung. Shin SW; Breathnach OS; Linnoila RI; Williams J; Gillespie JW; Kelley MJ; Johnson BE Oncology; 2001; 60(1):81-7. PubMed ID: 11150913 [TBL] [Abstract][Full Text] [Related]
7. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma. Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123 [TBL] [Abstract][Full Text] [Related]
8. The origins of multiple squamous cell carcinomas in the aerodigestive tract. van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719 [TBL] [Abstract][Full Text] [Related]
10. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Shimizu S; Yatabe Y; Koshikawa T; Haruki N; Hatooka S; Shinoda M; Suyama M; Ogawa M; Hamajima N; Ueda R; Takahashi T; Mitsudomi T Clin Cancer Res; 2000 Oct; 6(10):3994-9. PubMed ID: 11051248 [TBL] [Abstract][Full Text] [Related]
13. Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic single-strand conformation polymorphism analysis. Lau DH; Yang B; Hu R; Benfield JR Diagn Mol Pathol; 1997 Aug; 6(4):179-84. PubMed ID: 9360838 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. Mitsudomi T; Yatabe Y; Koshikawa T; Hatooka S; Shinoda M; Suyama M; Sugiura T; Ogawa M; Takahashi T J Thorac Cardiovasc Surg; 1997 Sep; 114(3):354-60. PubMed ID: 9305187 [TBL] [Abstract][Full Text] [Related]
15. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905 [TBL] [Abstract][Full Text] [Related]
16. Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene. Aotake T; Muraoka R; Matsukawa S; Tanigawa N Int J Oncol; 1998 Oct; 13(4):773-9. PubMed ID: 9735408 [TBL] [Abstract][Full Text] [Related]
17. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. Christiansen DH; Andersen MK; Pedersen-Bjergaard J J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1. Maruyama A; Miyamoto S; Saito T; Kondo H; Baba H; Tsukamoto N Cancer; 2001 Jun; 91(11):2056-64. PubMed ID: 11391585 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306 [TBL] [Abstract][Full Text] [Related]
20. Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers. Nonami Y; Ohtuki Y; Sasaguri S J Cardiovasc Surg (Torino); 2003 Oct; 44(5):661-5. PubMed ID: 14735056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]